NEW YORK (GenomeWeb News) – Bruker announced today an agreement to acquire the preclinical in vivo imaging equipment product portfolio and related assets from Carestream Health's Molecular Imaging business for an undisclosed amount.

The deal is expected to be completed in the next several weeks, Bruker said. The majority of employees in the Carestream business being bought by Bruker are being offered employment with Bruker.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.